D.E. Shaw & Co’s Diebold Nixdorf Incorporated DBD Stock Holding History

D.E. Shaw & Co’s Portfolio DBD Stock Details DBD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-683,846	Closed	-$821K	–	4768
2023 Q1	$821K	Sell	683,846 -1,996,491	-74%	-$4.44M	﹤0.01%	3293
2022 Q4	$3.81M	Buy	2,680,337 +115,316	+4%	+$247K	﹤0.01%	2348
2022 Q3	$6.26M	Sell	2,565,021 -150,547	-6%	-$502K	0.01%	1830
2022 Q2	$6.16M	Buy	2,715,568 +340,778	+14%	+$1.27M	0.01%	1883
2022 Q1	$16M	Buy	2,374,790 +41,001	+2%	+$351K	0.02%	1189
2021 Q4	$21.1M	Buy	2,333,789 +381,943	+20%	+$3.55M	0.02%	1057
2021 Q3	$19.7M	Buy	1,951,846 +61,089	+3%	+$670K	0.02%	1019
2021 Q2	$24.3M	Sell	1,890,757 -453,131	-19%	-$6.22M	0.02%	911
2021 Q1	$33.1M	Sell	2,343,888 -357,981	-13%	-$4.93M	0.03%	671
2020 Q4	$28.8M	Buy	2,701,869 +377,137	+16%	+$3.43M	0.03%	766
2020 Q3	$17.8M	Buy	2,324,732 +301,459	+15%	+$2.22M	0.02%	897
2020 Q2	$12.3M	Buy	2,023,273 +453,908	+29%	+$2.24M	0.01%	1069
2020 Q1	$5.52M	Sell	1,569,365 -470,046	-23%	-$3.98M	0.01%	1387
2019 Q4	$21.5M	Buy	2,039,411 +106,311	+5%	+$944K	0.02%	780
2019 Q3	$21.7M	Buy	1,933,100 +825,117	+74%	+$9.77M	0.03%	734
2019 Q2	$10.1M	Sell	1,107,983 -904,852	-45%	-$9.44M	0.01%	1131
2019 Q1	$22.3M	Buy	+2,012,835	New	+$14.1M	0.03%	677
2018 Q4	–	Sell	-61,457	Closed	-$277K	–	4075
2018 Q3	$277K	Buy	61,457 +15,947	+35%	+$116K	﹤0.01%	3397
2018 Q2	$544K	Sell	45,510 -408,569	-90%	-$5.47M	﹤0.01%	3068
2018 Q1	$6.99M	Buy	454,079 +74,048	+19%	+$1.24M	0.01%	1205
2017 Q4	$6.21M	Buy	380,031 +291,022	+327%	+$5.63M	0.01%	1345
2017 Q3	$2.03M	Buy	+89,009	New	+$1.9M	﹤0.01%	2007
2017 Q2	–	Sell	-12,245	Closed	-$376K	–	3593
2017 Q1	$376K	Sell	12,245 -35,086	-74%	-$991K	﹤0.01%	2870
2016 Q4	$1.19M	Sell	47,331 -180,744	-79%	-$4.26M	﹤0.01%	2355
2016 Q3	$5.65M	Buy	228,075 +14,265	+7%	+$379K	0.01%	1221
2016 Q2	$5.31M	Sell	213,810 -4,122	-2%	-$106K	0.01%	1247
2016 Q1	$6.3M	Buy	217,932 +158,697	+268%	+$4.15M	0.01%	1127
2015 Q4	$1.78M	Buy	59,235 +39,610	+202%	+$1.35M	﹤0.01%	2228
2015 Q3	$584K	Sell	19,625 -16,790	-46%	-$546K	﹤0.01%	2955
2015 Q2	$1.27M	Sell	36,415 -108,449	-75%	-$3.83M	﹤0.01%	2522
2015 Q1	$5.14M	Buy	+144,864	New	+$4.88M	0.01%	1368
2014 Q3	–	Sell	-11,885	Closed	-$477K	–	4456
2014 Q2	$477K	Sell	11,885 -134,665	-92%	-$5.17M	﹤0.01%	3567
2014 Q1	$5.85M	Buy	146,550 +48,900	+50%	+$1.76M	0.01%	1462
2013 Q4	$3.22M	Buy	97,650 +3,224	+3%	+$101K	﹤0.01%	2064
2013 Q3	$2.77M	Buy	94,426 +59,566	+171%	+$1.87M	﹤0.01%	2138
2013 Q2	$1.17M	Buy	+34,860	New	+$1.08M	﹤0.01%	2583

Other funds holding DBD

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

BFIM

Beese Fulmer Investment Management Canton, Ohio $1.56B AUM 26.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

D.E. Shaw & Co's DBD Position: Q2 2023 in Review

D.E. Shaw & Co sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2023, closing a stake of 683,846 shares — an estimated $821K sold.

D.E. Shaw & Co first reported a position in DBD in Q2 2013 and held it in 36 quarters. The position peaked at $33.1M in Q1 2021. 7 funds tracked by Wall St. Rank hold DBD as of Q2 2023.

D.E. Shaw & Co reported no remaining Diebold Nixdorf Incorporated position as of Q2 2023 after selling out during the quarter.
D.E. Shaw & Co sold 683,846 Diebold Nixdorf Incorporated shares in Q2 2023, an estimated $821K.
D.E. Shaw & Co first reported a position in Diebold Nixdorf Incorporated in Q2 2013 and held it in 36 quarters.
D.E. Shaw & Co's Diebold Nixdorf Incorporated position peaked at $33.1M in Q1 2021.
7 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2023.

Based on D.E. Shaw & Co's 13F filing for Q2 2023, filed 14 Aug 2023.